SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 72 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $27,783,000 | +58.5% | 1,547,788 | +4.2% | 0.01% | +50.0% |
| Q3 2017 | $17,525,000 | +6.3% | 1,485,160 | -5.4% | 0.01% | 0.0% |
| Q2 2017 | $16,487,000 | -3.6% | 1,570,172 | +1.0% | 0.01% | 0.0% |
| Q1 2017 | $17,101,000 | -19.1% | 1,554,644 | -0.3% | 0.01% | -27.3% |
| Q4 2016 | $21,130,000 | +17.9% | 1,559,433 | +7.1% | 0.01% | +10.0% |
| Q3 2016 | $17,917,000 | +15.4% | 1,455,447 | +2.8% | 0.01% | +11.1% |
| Q2 2016 | $15,525,000 | -4.6% | 1,415,265 | -5.0% | 0.01% | -10.0% |
| Q1 2016 | $16,280,000 | -38.6% | 1,489,487 | -2.8% | 0.01% | -41.2% |
| Q4 2015 | $26,496,000 | -6.5% | 1,532,411 | +7.5% | 0.02% | -10.5% |
| Q3 2015 | $28,333,000 | +37.2% | 1,425,948 | +13.5% | 0.02% | +46.2% |
| Q2 2015 | $20,649,000 | +29.3% | 1,256,768 | +22.4% | 0.01% | +30.0% |
| Q1 2015 | $15,974,000 | +16.1% | 1,026,614 | +6.6% | 0.01% | +11.1% |
| Q4 2014 | $13,753,000 | +135.4% | 963,123 | +7.1% | 0.01% | +125.0% |
| Q3 2014 | $5,843,000 | -6.4% | 898,950 | -0.6% | 0.00% | 0.0% |
| Q2 2014 | $6,242,000 | -1.2% | 904,599 | +2.4% | 0.00% | -20.0% |
| Q1 2014 | $6,316,000 | -17.2% | 883,320 | +8.9% | 0.01% | -16.7% |
| Q4 2013 | $7,624,000 | +51.4% | 811,069 | +0.5% | 0.01% | +50.0% |
| Q3 2013 | $5,035,000 | -5.5% | 806,930 | -0.4% | 0.00% | -20.0% |
| Q2 2013 | $5,328,000 | – | 809,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|